Rekvina Pharmaceuticals — Tramadol Exporter Profile
Indian Pharmaceutical Exporter · #4 for Tramadol · $3.3M export value · DGFT Verified
Rekvina Pharmaceuticals is the #4 Indian exporter of Tramadol with $3.3M in export value and 65 verified shipments. Rekvina Pharmaceuticals holds a 1.7% market share in Tramadol exports across 2 countries.
Rekvina Pharmaceuticals — Tramadol Export Profile: Buyers & Destinations
Where Does Rekvina Pharmaceuticals Export Tramadol?
| Country | Value | Shipments | Share |
|---|---|---|---|
| GERMANY | $3.0M | 63 | 96.8% |
| KYRGHYSTAN | $100.0K | 2 | 3.2% |
Rekvina Pharmaceuticals exports Tramadol to 2 countries. The largest destination is GERMANY accounting for 96.8% of Rekvina Pharmaceuticals's Tramadol shipments. These destinations reflect Rekvina Pharmaceuticals's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Tramadol from Rekvina Pharmaceuticals?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| M/S. S B PHARMA GMBH | GERMANY | $2.3M | 46 |
| S B PHARMA GMBH | GERMANY | $284.7K | 6 |
| MS S B PHARMA GMBH | GERMANY | $258.6K | 7 |
| MS SBPHARMA GMBH | GERMANY | $150.0K | 3 |
| M/S. TOM FARM GROUP | KYRGHYSTAN | $100.0K | 2 |
| M/S, S B PHARMA GMBH | GERMANY | $50.0K | 1 |
Rekvina Pharmaceuticals supplies Tramadol to 6 buyers globally. The largest buyer is M/S. S B PHARMA GMBH (GERMANY), followed by S B PHARMA GMBH (GERMANY) and MS S B PHARMA GMBH (GERMANY). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Tramadol Export Value and How Much Does Rekvina Pharmaceuticals Contribute?
India exported $67.2M worth of Tramadol through 3,928 shipments from 249 suppliers to 103 countries, serving 789 buyers globally. Rekvina Pharmaceuticals contributes $3.3M to this total, accounting for 1.7% of India's Tramadol exports. Rekvina Pharmaceuticals ships Tramadol to 2 countries through 6 buyers.
What Is the Average Shipment Value for Rekvina Pharmaceuticals's Tramadol Exports?
Rekvina Pharmaceuticals's average Tramadol shipment value is $50.0K per consignment, based on 65 shipments totaling $3.3M. The largest destination is GERMANY (96.8% of Rekvina Pharmaceuticals's Tramadol exports).
How Does Rekvina Pharmaceuticals Compare to Other Indian Tramadol Exporters?
Rekvina Pharmaceuticals ranks #4 among 249 Indian Tramadol exporters with a 1.7% market share. The top 3 exporters are RUBICON RESEARCH PRIVATE LIMITED ($11.4M), UNICHEM LABORATORIES LIMITED ($10.3M), MEDREICH LIMITED ($8.2M). Rekvina Pharmaceuticals processed 65 shipments to 2 destination countries.
What Tramadol Formulations Does Rekvina Pharmaceuticals Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| TRAMADOL HCL TABLET-TRAMAKING 225 TAB(10X10)(100 TAB IN A BOX) | $418.3K | 9 |
| Tramadol HCL tablet-TAMRAL 250(10 x 10 x720 x 75 boxes) | $300.0K | 6 |
| Tramadol HCL tablet-ROYAL 225(10 x 10 x720 x 75 boxes) | $200.0K | 4 |
| Tramadol HCL tablet - Tamol X 22510x10100 tab in a box | $150.0K | 3 |
| Tramadol HCL tablet-TRAMAKING 225(10 x 10 x 720 x 75 boxes) | $150.0K | 3 |
| TRAMADOL HCL TABLET - TRAMAKING 225 TAB(10X10)(100 TAB IN A BOX) | $150.0K | 3 |
| TRAMAKING 250 TABLETS TRAMADOL HCLTABLET, PACK: 10X10 (100 TAB IN ABOX) | $145.8K | 3 |
| Tramadol HCL tablet-Tramaking 225 TAB(10x10)(100 tab in a box) | $142.8K | 3 |
| TRAMAKING 225 TABLETS TRAMADOL HCLTABLET, PACK: 10X10 (100 TAB IN ABOX) | $138.9K | 3 |
| TRAMADOL HCL TABLET TRADE NAME TRAMOL X | $100.0K | 2 |
Rekvina Pharmaceuticals exports 28 distinct Tramadol formulations including tablets, capsules, syrups, and combination drugs. The top formulation is TRAMADOL HCL TABLET-TRAMAKING 225 TAB(10X10)(100 TAB IN A B with 9 shipments worth $418.3K.
Regulatory Requirements: Exporting Tramadol to Key Markets
What Rekvina Pharmaceuticals must comply with to export Tramadol to its top destination countries
Germany — BfArM/EMA
Approval Process
Marketing Authorisation via Decentralized or Mutual Recognition Procedure under EU Directive 2001/83/EC. CTD Module 1–5 dossier required.
Timeline: 12–18 months via Decentralized Procedure
GMP & Export Requirements
EU GMP (EudraLex Vol. 4); GMP certificate from EU competent authority; WHO Prequalification accepted as supporting evidence
Certificate of Pharmaceutical Product (CPP) from CDSCO; Written Confirmation for API export per EU requirements; EU FMD serialization mandatory
Note: Indian manufacturers must hold EU GMP certificate. EU Falsified Medicines Directive (FMD) serialization and tamper-evident packaging mandatory.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Rekvina Pharmaceuticals Compare to Nearest Tramadol Exporters?
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED | $4.2M | 83 | 1 | $50.0K |
| 11 | AUROBINDO PHARMA LTD | $3.6M | 183 | 4 | $19.5K |
| 4 | REKVINA PHARMACEUTICALS ★ | $3.3M | 65 | 2 | $50.0K |
| 12 | SRI KRISHNA PHARMACEUTICALS LIMITED | $3.2M | 111 | 1 | $28.8K |
| 14 | IPCA LABORATORIES LIMITED | $1.0M | 20 | 6 | $50.0K |
Rekvina Pharmaceuticals ranks #4 among 249 Indian Tramadol exporters. Average shipment value of $50.0K compared to the market average of $270.0K. The closest competitors by value are AMNEAL PHARMACEUTICALS PRIVATE LIMITED and AUROBINDO PHARMA LTD.
Which Indian Ports Ship Tramadol Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 463 | 11.8% |
| SAHAR AIR | 405 | 10.3% |
| JNPT/ NHAVA SHEVA SEA | 289 | 7.4% |
| SAHAR AIR CARGO ACC (INBOM4) | 264 | 6.7% |
| JNPT | 199 | 5.1% |
| MUNDRA SEA | 150 | 3.8% |
| VIZAG SEA | 108 | 2.7% |
| BANGALORE ICD | 106 | 2.7% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Tramadol — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Tramadol shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Rekvina Pharmaceuticals matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 65 individual customs records matching Rekvina Pharmaceuticals exporting Tramadol, covering 28 formulations to 2 countries via 6 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 103+ countries, 789+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Tramadol Export Data from Rekvina Pharmaceuticals
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Rekvina Pharmaceuticals's Tramadol exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Rekvina Pharmaceuticals
Company Profile
0 products · $0 total trade · 0 categories
Tramadol Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Rekvina Pharmaceuticals.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Tramadol. For current shipment-level data, contact TransData Nexus.